Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Weight Loss 1Lung Neoplasms 1Fatigue 1Depression 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Anxiety Disorders 1Advanced Cancer 1Adenocarcinoma of Lung 1

Interventions

Therapeutics 9Psychiatric Rehabilitation 9Music Therapy 8Cognitive Behavioral Therapy 7Mindfulness 6Surveys and Questionnaires 5Counseling 5Acupuncture Therapy 5Standard of Care 4Mindfulness-Based Stress Reduction 4Methods 4Imagery, Psychotherapy 4Early Intervention, Educational 4Autogenic Training 4Art Therapy 4Therapeutic Touch 3Psychosocial Intervention 3Psilocybin 3Mindfulness-Based Cognitive Therapy 3Massage 3Hypnosis 3Exercise 3Control Groups 3Aromatherapy 3Acceptance and Commitment Therapy 3Yoga 2Touch 2Observation 2Niacin 2Gabapentin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anxiety Disorders × Fluoxetine × Clear all
NCT00005850 2016-07-04

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
21 enrolled
Thoracic

Adenocarcinoma of Lung, Anxiety Disorders, Carcinoma, Non-Small-Cell Lung, Depression, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡